Magic mushrooms may reduce stress and anxiety about hair, potentially affecting hairloss. Users report feeling better about their hair after using mushrooms.
Scalp micropigmentation (SMP) is a viable option for those experiencing hairloss, providing a natural look similar to a buzzcut. It requires touch-ups every 3-5 years, and using products like zero shine can help manage appearance issues in different lighting.
The user is considering a hair transplant for frontal temple density but is concerned about shock loss. They have been using finasteride for about two years and are advised to consider minoxidil and microneedling for better results.
A clinical trial in Australia offers $20,000 for participation, aiming to regrow hair and reverse grey hair. Participants must not have used hair treatments recently and must visit a Melbourne clinic regularly over 18 months.
Finasteride and dutasteride are discussed as preventative treatments for hairloss, with some advocating for early use and others concerned about side effects, especially before full maturity. Many regret not starting these treatments earlier due to their effectiveness in preventing or slowing hairloss.
The FDA policy change may speed up approval for hairloss drugs like PP405, VDPHL-01, and Breezula by potentially eliminating the need for a second confirmatory Phase 3 trial. Approval timelines could be as early as 2028 for some treatments if Phase 3 results are strong.
The user is considering starting a 6-month treatment with minoxidil and finasteride for hairloss but is unsure due to minimal current hairloss and concerns about mental health effects from oral finasteride. They are uncertain about the correct application areas for these treatments.
A user created a web app called TrichoMetrics to track hairloss using photos and metrics like density and thinning. The app supports tracking treatments like Minoxidil and finasteride, with features for setting baselines, comparing progress, and logging treatment adherence.
The user seeks advice on booking a dermatologist in the UK for hairloss treatment. They mention long wait times through a GP and inquire about private options in London.
Minoxidil and spironolactone are recommended for female hairloss, and they can be used together. A dermatologist visit is advised to confirm the type of hairloss and rule out other issues.
Minoxidil alone can work for some people, but it may not address DHT-related hairloss. Adding a derma roller and using ketoconazole shampoo might improve results.
The user is considering using 0.5mg Dutasteride and 2.5mg Minoxidil for hairloss reversal. Another user advises consulting a doctor and getting bloodwork and a trichoscopy before starting the treatment.
Topical tretinoin applied to the face may exacerbate hairloss in some individuals, potentially triggering conditions like frontal fibrosing alopecia. Experiences vary, with some users reporting no impact on hair, while others experience significant hairloss.
A 24-year-old from Istanbul has experienced hairloss for 3-4 years, used minoxidil without results, and recently started topical finasteride. Hair shedding has increased in the last 6 months, and they are seeking advice on what to expect.
A new treatment, clascoterone 5% solution, shows significant improvement in male hairloss but is considered expensive and only slightly effective by some. It has no side effects and may influence market competition.
A 15-year-old is seeking advice on preventing hairloss, identified as Norwood level 2, and wants tips for growing long hair. They have consulted a trichologist who recommended specific shampoos.
A doctor advised against using finasteride or dutasteride for hairloss, suggesting PRP or mesotherapy instead, which led to skepticism about his motives. Many users recommended finding a new doctor and shared experiences of successful treatments with finasteride or dutasteride.
The user stopped taking Finasteride after 8 years to try for kids but noticed hairloss and reduced anxiety. They are considering resuming Finasteride to prevent further hairloss.
Prolactin and cortisol are identified as key factors in hairloss, with stress hormones impacting hair shedding. Finasteride and minoxidil are effective treatments, while DHT's role and individual sensitivity are significant factors.
A user is considering starting finasteride at a lower dose to prevent hairloss but is concerned about potential side effects. They seek advice on whether others have had positive experiences with minimal side effects.
Scientists claim a combination of caffeine, two proteins, and Centella asiatica extracts can cure hairloss, but skepticism remains due to past unfulfilled promises. Users discuss various treatments like minoxidil, finasteride, and microneedling, expressing doubt about the effectiveness of new methods.
A 26-year-old man with diffuse alopecia is using electric scalp massage, dermastamp, and multivitamins for treatment but is intolerant to finasteride. A dermatologist recommended PRP and mesotherapy with exosomes and dutasteride.
A 16-year-old is considering using 5% topical minoxidil for hairloss at the temples and crown but is concerned about potential issues from not using finasteride due to age restrictions. They plan to start minoxidil now and consider adding finasteride at 18 if available.
An 18-year-old in India is seeking a dutasteride prescription for aggressive hairloss, as family members are bald by age 20. Local doctors advised against it, so they are considering using Indian telemedicine apps for a prescription.
A 27-year-old male experienced limited success with Dutasteride and topical Minoxidil for hairloss and eyebrow thinning, with side effects like decreased libido and erectile dysfunction. He is considering oral Minoxidil but is concerned about side effects, and is advised to try ketoconazole for possible dermatitis and monitor vitamin D levels.
A 30-year-old female shares her positive progress with hair regrowth using topical minoxidil and vitamins, after experiencing hairloss since her early 20s. She mentions using a product with a natural DHT blocker and emphasizes the importance of checking vitamin and iron levels.
GT20029 is discussed as a potential treatment for androgenetic hairloss by targeting androgen receptors, unlike finasteride which reduces DHT broadly. Concerns include its effectiveness, genetic variations in androgen receptors, and availability, with some skepticism about its potential as a true alternative.
A 19-year-old male is experiencing hairloss and has been prescribed 5% minoxidil and ketoconazole shampoo but is unsure about starting finasteride. He plans to begin using minoxidil soon and is seeking advice on whether to add finasteride to his treatment.
A 17-year-old is concerned about hairloss and is considering treatments like Minoxidil, finasteride, and RU58841. They feel uncertain about whether to start treatment.